T. Rowe Price Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03B | Sell |
3,145,006
-360,162
| -10% | -$117M | 0.12% | 162 |
|
|
2025
Q1 | $946M | Buy |
3,505,168
+185,783
| +6% | +$50.2M | 0.12% | 176 |
|
|
2024
Q4 | $781M | Sell |
3,319,385
-132,448
| -4% | -$31.2M | 0.09% | 199 |
|
|
2024
Q3 | $949M | Sell |
3,451,833
-36,170
| -1% | -$9.95M | 0.11% | 176 |
|
|
2024
Q2 | $848M | Sell |
3,488,003
-197,750
| -5% | -$48.1M | 0.1% | 179 |
|
|
2024
Q1 | $551M | Buy |
3,685,753
+201,784
| +6% | +$30.2M | 0.07% | 259 |
|
|
2023
Q4 | $667M | Sell |
3,483,969
-441,035
| -11% | -$84.4M | 0.09% | 212 |
|
|
2023
Q3 | $695M | Buy |
3,925,004
+39,468
| +1% | +$6.99M | 0.1% | 199 |
|
|
2023
Q2 | $738M | Sell |
3,885,536
-87,340
| -2% | -$16.6M | 0.1% | 194 |
|
|
2023
Q1 | $796M | Sell |
3,972,876
-101,268
| -2% | -$20.3M | 0.12% | 180 |
|
|
2022
Q4 | $968M | Buy |
4,074,144
+353,538
| +10% | +$84M | 0.16% | 140 |
|
|
2022
Q3 | $745M | Sell |
3,720,606
-3,276,476
| -47% | -$656M | 0.12% | 166 |
|
|
2022
Q2 | $1.02B | Buy |
6,997,082
+202,916
| +3% | +$29.6M | 0.13% | 170 |
|
|
2022
Q1 | $1.11B | Buy |
6,794,166
+258,798
| +4% | +$42.3M | 0.11% | 188 |
|
|
2021
Q4 | $1.11B | Buy |
6,535,368
+661,133
| +11% | +$112M | 0.1% | 201 |
|
|
2021
Q3 | $1.11B | Buy |
5,874,235
+349,557
| +6% | +$66M | 0.1% | 201 |
|
|
2021
Q2 | $937M | Sell |
5,524,678
-50,535
| -0.9% | -$8.57M | 0.09% | 245 |
|
|
2021
Q1 | $787M | Sell |
5,575,213
-129
| -0% | -$18.2K | 0.08% | 261 |
|
|
2020
Q4 | $725M | Sell |
5,575,342
-439,509
| -7% | -$57.1M | 0.07% | 267 |
|
|
2020
Q3 | $876M | Sell |
6,014,851
-257,575
| -4% | -$37.5M | 0.1% | 211 |
|
|
2020
Q2 | $929M | Sell |
6,272,426
-15,334
| -0.2% | -$2.27M | 0.12% | 186 |
|
|
2020
Q1 | $684M | Buy |
6,287,760
+936,668
| +18% | +$102M | 0.11% | 200 |
|
|
2019
Q4 | $616M | Buy |
5,351,092
+467,438
| +10% | +$53.8M | 0.08% | 264 |
|
|
2019
Q3 | $393M | Buy |
4,883,654
+1,375,040
| +39% | +$111M | 0.06% | 320 |
|
|
2019
Q2 | $255M | Buy |
3,508,614
+25,025
| +0.7% | +$1.82M | 0.04% | 408 |
|
|
2019
Q1 | $326M | Sell |
3,483,589
-192,236
| -5% | -$18M | 0.05% | 346 |
|
|
2018
Q4 | $268M | Sell |
3,675,825
-524,930
| -12% | -$38.3M | 0.05% | 359 |
|
|
2018
Q3 | $368M | Sell |
4,200,755
-1,013,208
| -19% | -$88.7M | 0.05% | 339 |
|
|
2018
Q2 | $514M | Sell |
5,213,963
-7,355,371
| -59% | -$724M | 0.08% | 246 |
|
|
2018
Q1 | $1.5B | Buy |
12,569,334
+336,093
| +3% | +$40M | 0.24% | 93 |
|
|
2017
Q4 | $1.55B | Buy |
12,233,241
+3,668,358
| +43% | +$466M | 0.25% | 92 |
|
|
2017
Q3 | $1.01B | Buy |
8,564,883
+1,896,280
| +28% | +$223M | 0.17% | 136 |
|
|
2017
Q2 | $532M | Buy |
6,668,603
+2,500,634
| +60% | +$199M | 0.1% | 238 |
|
|
2017
Q1 | $214M | Buy |
4,167,969
+4,255
| +0.1% | +$218K | 0.04% | 418 |
|
|
2016
Q4 | $156M | Buy |
4,163,714
+138,306
| +3% | +$5.18M | 0.03% | 476 |
|
|
2016
Q3 | $273M | Buy |
4,025,408
+29,266
| +0.7% | +$1.98M | 0.05% | 335 |
|
|
2016
Q2 | $222M | Buy |
3,996,142
+2,712,060
| +211% | +$150M | 0.05% | 385 |
|
|
2016
Q1 | $80.6M | Buy |
1,284,082
+46,237
| +4% | +$2.9M | 0.02% | 610 |
|
|
2015
Q4 | $117M | Sell |
1,237,845
-82,350
| -6% | -$7.75M | 0.02% | 521 |
|
|
2015
Q3 | $106M | Sell |
1,320,195
-391,099
| -23% | -$31.4M | 0.02% | 556 |
|
|
2015
Q2 | $205M | Buy |
1,711,294
+449,690
| +36% | +$53.9M | 0.04% | 439 |
|
|
2015
Q1 | $132M | Buy |
1,261,604
+19,578
| +2% | +$2.04M | 0.03% | 537 |
|
|
2014
Q4 | $120M | Sell |
1,242,026
-1,942,036
| -61% | -$188M | 0.03% | 567 |
|
|
2014
Q3 | $249M | Sell |
3,184,062
-67,971
| -2% | -$5.31M | 0.05% | 383 |
|
|
2014
Q2 | $205M | Sell |
3,252,033
-342,698
| -10% | -$21.6M | 0.04% | 429 |
|
|
2014
Q1 | $241M | Sell |
3,594,731
-219,314
| -6% | -$14.7M | 0.05% | 393 |
|
|
2013
Q4 | $245M | Sell |
3,814,045
-422,690
| -10% | -$27.2M | 0.06% | 382 |
|
|
2013
Q3 | $271M | Buy |
4,236,735
+1,928,635
| +84% | +$123M | 0.07% | 333 |
|
|
2013
Q2 | $71.6M | Buy |
+2,308,100
| New | +$71.6M | 0.02% | 672 |
|